FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079893537> ?p ?o ?g. }

• W2079893537 endingPage "1210" @default.
• W2079893537 startingPage "1204" @default.
• W2079893537 abstract "Myxoid and round cell liposarcomas constitute approximately one-third of all liposarcomas, a relatively common group of fat-derived soft tissue sarcomas. The histomorphology is a continuum between highly differentiated myxoid and poorly differentiated round cell components. The gold standard of diagnosis is dependent on histomorphology and/or identification of t(12;16)(q13;p11) translocation by cytogenetics or demonstration of DDIT3 rearrangements by fluorescence in situ hybridization. There are currently no diagnostic immunohistochemical stains available. The broad range of myxoid neoplasms in the differential diagnosis includes a variety of sarcomas. Given the notable differences in disease biology among myxoid neoplasms, which range from benign to aggressive, an accurate diagnosis is imperative for proper treatment and prognostication. Prompted by our recent study showing frequent expression of the cancer testis antigen NY-ESO-1 in myxoid and round cell liposarcomas, we sought to evaluate the utility of NY-ESO-1 as an immunohistochemical marker for myxoid and round cell liposarcoma among mesenchymal myxoid neoplasms within the differential diagnosis. Formalin-fixed, paraffin-embedded blocks were obtained for the following mesenchymal myxoid neoplasms (n=138): myxoid and round cell liposarcoma (n=38); well-differentiated liposarcoma (n=12); lipoma (n=20; 4 with myxoid change); extra-cardiac soft tissue myxoma (n=39); extraskeletal myxoid chondrosarcoma (n=12); myxofibrosarcoma (n=10: 5 low grade, 2 intermediate grade, 3 high grade); and low-grade fibromyxoid sarcoma (n=7). Utilizing standard immunohistochemistry protocols, full sections were stained with NY-ESO-1 (clone E978), and staining was assessed for intensity (1-2+), percentage of tumor positivity, and location. In all, 36/38 (95%) of the myxoid and round cell liposarcomas demonstrated NY-ESO-1 immunoreactivity. The majority of the positive cases (34/36; 94%) showed strong, homogenous staining (>50% tumor positivity), and two cases (6%) showed weak (1+ intensity), patchy staining (20-30% tumor positivity). Immunoreactivity was predominantly cytoplasmic. All the other neoplasms evaluated were negative for NY-ESO-1. NY-ESO-1 appears to be a sensitive and a specific marker for myxoid and round cell liposarcoma among mesenchymal myxoid neoplasms. The assessment of NY-ESO-1 expression by immunohistochemistry in the appropriate setting provides a cheaper, faster, and more accessible confirmatory test." @default.
• W2079893537 created "2016-06-24" @default.
• W2079893537 creator A5008223734 @default.
• W2079893537 creator A5011515291 @default.
• W2079893537 date "2013-09-01" @default.
• W2079893537 modified "2023-10-01" @default.
• W2079893537 title "NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms" @default.
• W2079893537 cites W1572718168 @default.
• W2079893537 cites W1970087181 @default.
• W2079893537 cites W1986592841 @default.
• W2079893537 cites W2011380060 @default.
• W2079893537 cites W2020096461 @default.
• W2079893537 cites W2034481373 @default.
• W2079893537 cites W2034846292 @default.
• W2079893537 cites W2042174530 @default.
• W2079893537 cites W2047382244 @default.
• W2079893537 cites W2063813632 @default.
• W2079893537 cites W2065595206 @default.
• W2079893537 cites W2071772278 @default.
• W2079893537 cites W2071825091 @default.
• W2079893537 cites W2075623706 @default.
• W2079893537 cites W2079842158 @default.
• W2079893537 cites W2082063053 @default.
• W2079893537 cites W2098337213 @default.
• W2079893537 cites W2131638796 @default.
• W2079893537 cites W2137088550 @default.
• W2079893537 cites W2144684946 @default.
• W2079893537 cites W2153712501 @default.
• W2079893537 cites W2165142928 @default.
• W2079893537 doi "https://doi.org/10.1038/modpathol.2013.65" @default.
• W2079893537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23599152" @default.
• W2079893537 hasPublicationYear "2013" @default.
• W2079893537 type Work @default.
• W2079893537 sameAs 2079893537 @default.
• W2079893537 citedByCount "36" @default.
• W2079893537 countsByYear W20798935372014 @default.
• W2079893537 countsByYear W20798935372015 @default.
• W2079893537 countsByYear W20798935372016 @default.
• W2079893537 countsByYear W20798935372017 @default.
• W2079893537 countsByYear W20798935372018 @default.
• W2079893537 countsByYear W20798935372019 @default.
• W2079893537 countsByYear W20798935372020 @default.
• W2079893537 countsByYear W20798935372021 @default.
• W2079893537 countsByYear W20798935372022 @default.
• W2079893537 countsByYear W20798935372023 @default.
• W2079893537 crossrefType "journal-article" @default.
• W2079893537 hasAuthorship W2079893537A5008223734 @default.
• W2079893537 hasAuthorship W2079893537A5011515291 @default.
• W2079893537 hasBestOaLocation W20798935371 @default.
• W2079893537 hasConcept C104317684 @default.
• W2079893537 hasConcept C142724271 @default.
• W2079893537 hasConcept C204232928 @default.
• W2079893537 hasConcept C2777542201 @default.
• W2079893537 hasConcept C2778256501 @default.
• W2079893537 hasConcept C2779568860 @default.
• W2079893537 hasConcept C2780801072 @default.
• W2079893537 hasConcept C2781225692 @default.
• W2079893537 hasConcept C2910450773 @default.
• W2079893537 hasConcept C30481170 @default.
• W2079893537 hasConcept C55493867 @default.
• W2079893537 hasConcept C71924100 @default.
• W2079893537 hasConcept C86803240 @default.
• W2079893537 hasConceptScore W2079893537C104317684 @default.
• W2079893537 hasConceptScore W2079893537C142724271 @default.
• W2079893537 hasConceptScore W2079893537C204232928 @default.
• W2079893537 hasConceptScore W2079893537C2777542201 @default.
• W2079893537 hasConceptScore W2079893537C2778256501 @default.
• W2079893537 hasConceptScore W2079893537C2779568860 @default.
• W2079893537 hasConceptScore W2079893537C2780801072 @default.
• W2079893537 hasConceptScore W2079893537C2781225692 @default.
• W2079893537 hasConceptScore W2079893537C2910450773 @default.
• W2079893537 hasConceptScore W2079893537C30481170 @default.
• W2079893537 hasConceptScore W2079893537C55493867 @default.
• W2079893537 hasConceptScore W2079893537C71924100 @default.
• W2079893537 hasConceptScore W2079893537C86803240 @default.
• W2079893537 hasIssue "9" @default.
• W2079893537 hasLocation W20798935371 @default.
• W2079893537 hasLocation W20798935372 @default.
• W2079893537 hasOpenAccess W2079893537 @default.
• W2079893537 hasPrimaryLocation W20798935371 @default.
• W2079893537 hasRelatedWork W1973455501 @default.
• W2079893537 hasRelatedWork W1975249349 @default.
• W2079893537 hasRelatedWork W1976814678 @default.
• W2079893537 hasRelatedWork W2064470586 @default.
• W2079893537 hasRelatedWork W2408885096 @default.
• W2079893537 hasRelatedWork W2515962388 @default.
• W2079893537 hasRelatedWork W2533496023 @default.
• W2079893537 hasRelatedWork W2622765308 @default.
• W2079893537 hasRelatedWork W4226138464 @default.
• W2079893537 hasRelatedWork W4377103162 @default.
• W2079893537 hasVolume "26" @default.
• W2079893537 isParatext "false" @default.
• W2079893537 isRetracted "false" @default.
• W2079893537 magId "2079893537" @default.
• W2079893537 workType "article" @default.